학술논문
Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials
Document Type
Article
Author
Source
In: Cancer Medicine . (Cancer Medicine, August 2023, 12(16):16859-16868)
Subject
Language
English
ISSN
20457634